{"id":6450,"date":"2025-02-13T08:50:34","date_gmt":"2025-02-13T07:50:34","guid":{"rendered":"https:\/\/ekfz.uni-goettingen.de\/notifications\/"},"modified":"2026-05-06T12:16:34","modified_gmt":"2026-05-06T10:16:34","slug":"notifications","status":"publish","type":"page","link":"https:\/\/ekfz.uni-goettingen.de\/en\/notifications\/","title":{"rendered":"Notifications"},"content":{"rendered":"
[vc_row row_type=”main-section” stukram_section_layout=”section_grid”][vc_column][vc_row_inner][vc_column_inner width=”5\/6″][vc_column_text]

2026<\/h2>
\n
\n 8. May 2026<\/span>\n | <\/span>\n EKFZ Academy Workshop<\/span>\n <\/div>\n\n

How can medical device approval be achieved in a complex regulatory environment?<\/h2>\n\n
\n

This central question was addressed as part of the EKFZ Academy workshop “Medical Devices \u2013 Quality and Regulatory Overview”, led by Dr. Sabine Hauck.<\/p>\n <\/div>\n\n \n \ud83d\udd17<\/span>\n Read Article <\/a>\n <\/div>\n

\n
\n 7. May 2026<\/span>\n | <\/span>\n Message<\/span>\n <\/div>\n\n

Else Kr\u00f6ner Professorship for Translational Ophthalmology<\/h2>\n\n
\n

Dr. Christian van Oterendorp will assume the Else Kr\u00f6ner Professorship for Translational Ophthalmology on May 1, 2026, at the Department of Ophthalmology, University Medical Center G\u00f6ttingen. <\/p>\n <\/div>\n\n \n \ud83d\udd17<\/span>\n Read Article <\/a>\n <\/div>\n

\n
\n 20. April 2026<\/span>\n | <\/span>\n Message<\/span>\n <\/div>\n\n

“Science goes City”<\/h2>\n\n
\n

On April 19, 2026, science came directly to interested visitors. Under the motto “Science goes City”, G\u00f6ttingen\u2019s city center turned into a huge hands-on experience zone for joining in, trying things out, and marveling. <\/p>\n

From 12 to 6 PM, over 60 activities, diverse experiments, and fascinating insights into current research were presented. Whether strolling through the pedestrian zone or visiting your favorite shops: exciting stations are waiting to be discovered everywhere. <\/p>\n <\/div>\n\n \n \ud83d\udd17<\/span>\n Read Article <\/a>\n <\/div>\n

\n
\n 20. April 2026<\/span>\n | <\/span>\n Message<\/span>\n <\/div>\n\n

Science Festival 2026 at the new Community Center<\/h2>\n\n
\n

January 28\u201329, 2026 at the Community Center of the XLAB Foundation, G\u00f6ttingen<\/h4>\n

This year\u2019s Science Festival took place at the new XLAB Foundation community center. To mark the opening of the center, outstanding scientists were invited to share insights into their research\u2014ranging from contemporary European history and super-resolution microscopy to hearing research, astrophysics, and RNA viruses. Speakers also included Prof. Tobias Moser, Director of the Institute for Auditory Neuroscience. He showed how astonishingly precise hearing is organized physically and biologically, and where it typically \u201cbreaks down.\u201d Hair cells convert the tiniest mechanical vibrations into electrical signals, and the downstream synapses act as high-performance transmitters with extremely precise timing. This mechanism also reveals targets for therapies, ranging from molecular repair and gene therapy to improved cochlear implants. A particularly forward-looking approach is the \u201coptical cochlear implant\u201d with optogenetic stimulation, which promises more precise activation of the auditory nerve than traditional electrical stimulation. <\/p>\n <\/div>\n\n \n \ud83d\udd17<\/span>\n Read Article <\/a>\n <\/div>\n

\n
\n 9. April 2026<\/span>\n | <\/span>\n Press Release<\/span>\n <\/div>\n\n

Auditory Neuroscience and Optogenetics Stem Cell and Regenerative Biology<\/h2>\n\n
\n
\n
\n

Genetically Modified Common Marmosets as a Model for Human Deafness<\/h4>\n<\/div>\n
\n

Why are some people unable to hear from birth\u2014even though their inner ear appears to be intact? One possible cause lies in the so-called OTOF<\/i> gene. It plays a central role in transmitting sound signals from the hair cells to the auditory nerve. If this function is missing, acoustic information does not reach the brain. Researchers from the German Primate Center \u2013 Leibniz Institute for Primate Research, together with University Medical Center G\u00f6ttingen and the Max Planck Institute for Multidisciplinary Sciences, have now generated common marmosets in which this gene was specifically knocked out for the first time. The animals are healthy and develop normally, but are deaf from birth. This provides the first primate model that realistically represents key forms of human deafness (Nature Communications). <\/p>\n

\"\"
\nCopyright: DPZ\/Katharina Diederich<\/span><\/p>\n<\/div>\n<\/div>\n <\/div>\n\n \n \ud83d\udd17<\/span>\n Read Article <\/a>\n <\/div>\n

\n
\n 7. April 2026<\/span>\n | <\/span>\n Press Release<\/span>\n <\/div>\n\n

Patient Action Day at UMG on age-related macular degeneration<\/h2>\n\n
\n

Text becomes distorted and crooked, letters disappear, faces are no longer recognized, and even the best glasses no longer help. According to the Professional Association of Ophthalmologists in Germany (BVA), age-related macular degeneration (AMD) affects more than seven million people in Germany and, at 50%, is the most common cause of severe visual impairment, which can also lead to blindness. <\/p>\n

1st Patient Action Day on age-related macular degeneration (AMD)<\/strong>
\nSaturday, April 18, 2026, 10:00 AM to 3:00 PM<\/strong>
\nLecture Hall 552 and East Hall, University Medical Center G\u00f6ttingen, Robert-Koch-Stra\u00dfe 40, 37075 G\u00f6ttingen<\/strong><\/p>\n <\/div>\n\n \n \ud83d\udd17<\/span>\n Read Article <\/a>\n <\/div>\n

\n
\n 7. April 2026<\/span>\n | <\/span>\n Message<\/span>\n <\/div>\n\n

How new therapies save our hearing<\/h2>\n\n
\n

Around 16 million people in Germany no longer hear well\u2014and the trend is rising. The good news: hearing technology is becoming ever more sophisticated. A new implant uses light signals to achieve what was previously impossible. <\/p>\n <\/div>\n\n \n \ud83d\udd17<\/span>\n Read Article <\/a>\n <\/div>\n

\n
\n 4. March 2026<\/span>\n | <\/span>\n Message<\/span>\n <\/div>\n\n

German Society for Biomedical Engineering (DGBMT) TECH TALK series: Neurotechnologies for the future of medicine<\/h2>\n\n
\n

The DGBMT TECH TALK series “Applications of neurotechnology: From nerve monitoring to nerve stimulation” provides a concise overview of clinical applications, technical solutions, and current innovation dynamics in neurotechnology and neuroprosthetics.<\/p>\n

Applications of neurotechnology from a clinical perspective: From nerve monitoring to nerve stimulation
\nThe focus is on benefits for patients and guideline-based therapy that is intended to replace existing approaches. All information should be supported by case numbers. The topic area is introduced and placed in the context of the regulatory and economic framework conditions in Germany. <\/p>\n

Speakers
\nProf. Dr. med. Steffen Rosahl, Neurosurgery, Helios Klinikum Erfurt
\nProf. Dr.-Ing. Thomas Stieglitz, IMTEK, University of Freiburg<\/p>\n <\/div>\n\n \n \ud83d\udd17<\/span>\n Read Article <\/a>\n <\/div>\n

\n
\n 5. March 2026<\/span>\n | <\/span>\n Message<\/span>\n <\/div>\n\n

Neurotech in Germany: How to combine innovation and responsibility?<\/h2>\n\n
\n

Thomas Stieglitz is contributing to the VDI Initiative “Zukunft Deutschland 2050” in the field of Neurotech and AI as part of “Zukunft Medizintechnik 2050” and shares his thoughts on this topic jointly with others in this campaign.<\/p>\n <\/div>\n\n \n \ud83d\udd17<\/span>\n Read Article <\/a>\n <\/div>\n

\n
\n 21. January 2026<\/span>\n | <\/span>\n EKFZ Academy Workshop<\/span>\n <\/div>\n\n

Scientific Advice by PEI and CHMP<\/h2>\n\n
\n

What is scientific advice, how is it done and what is expected from the applicant?<\/p>\n

These relevant questions were addressed during last week\u2019s EKFZ Academy workshop. Dr. Jens Reinhardt, a regulatory scientist at Paul-Ehrlich-Institut (PEI) and member of the Scientific Advice Working Party of the European Medicines Agency (EMA), presented the advice possibilities given by the upper regulatory agencies in Germany and the Scientific Advice Working Party at EMA.<\/p>\n <\/div>\n\n \n \ud83d\udd17<\/span>\n Read Article <\/a>\n <\/div>\n

\n
\n 12. January 2026<\/span>\n | <\/span>\n EKFZ Academy Workshop<\/span>\n <\/div>\n\n

From Good Manufacturing Practice (GMP) to Good Clinical Practice (GCP)<\/h2>\n\n
\n

In November and December, the EKFZ Academy hosted two workshops dealing with the regulations and guidelines for the safe, effective, and high-quality manufacture and testing of medicinal products.<\/p>\n

Dr. Sabine Hauck addressed the GMP standards for the manufacture of Advanced Therapy Medicinal Products (ATMPs) and guided the audience through the requirements for GMP documentation. Based on her broad expertise in the life science industry, she also provided valuable insights into the interaction with contract manufacturers and highlighted the interface to GCP. <\/p>\n <\/div>\n\n \n \ud83d\udd17<\/span>\n Read Article <\/a>\n <\/div>\n

\n
\n 8. January 2026<\/span>\n | <\/span>\n Press Release<\/span>\n <\/div>\n\n

Young scientist researches restoration of vision<\/h2>\n\n
\n

Dr. Patrick Jendritza from the Salk Institute for Biological Studies, USA, has been awarded a “Junior Fellow Position” at the Else Kr\u00f6ner Fresenius Center for Optogenetic Therapies (EKFZ-OT) at the University Medical Center G\u00f6ttingen (UMG). Since January 1, 2026, the young scientist has been heading the “Visual Circuits” research group, which focuses on the development of light-controlled brain-computer interfaces for restoring vision. The research group, based at the German Primate Center – Leibniz Institute for Primate Research (DPZ), is being funded by the Else Kr\u00f6ner-Fresenius Foundation and the Lower Saxony Ministry of Science and Culture with a total of around 480,000 euros for an initial period of three years and three months. <\/p>\n <\/div>\n\n \n \ud83d\udd17<\/span>\n Read Article <\/a>\n <\/div>\n <\/div><\/div>[\/vc_column_text][\/vc_column_inner][vc_column_inner width=”1\/6″][vc_column_text]